ReShape Lifesciences Inc. (RSLS) Financials

Stock symbol RSLS is outdated, potentially delisted? Maybe it is available on other exchange?

RSLS Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2024	5.6 million	4.1 million
June 30, 2024	6.4 million	3.4 million
March 31, 2024	8.2 million	3.7 million
Dec. 31, 2023	10.7 million	4.1 million

RSLS Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2024	-311000	32000
June 30, 2024	-1.4 million	65000
March 31, 2024	-2.1 million	72000
Dec. 31, 2023	-2.5 million	110000

RSLS Net Income

No data available :(

RSLS Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2024	743000	77000	191000
June 30, 2024	1.1 million	103000	216000
March 31, 2024	2.5 million	127000	239000
Dec. 31, 2023	4.6 million	151000	262000

RSLS Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2024	508851
June 30, 2024	434869
March 31, 2024	404433
Dec. 31, 2023	404431

RSLS Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2024	-	399000	2.8 million	719000
June 30, 2024	-	399000	2.8 million	670000
March 31, 2024	-	484000	2.9 million	1.0 million
Dec. 31, 2023	-	739000	3.0 million	1.4 million

RSLS Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2024	2.3 million	853000
June 30, 2024	2.0 million	831000
March 31, 2024	1.9 million	779000
Dec. 31, 2023	2.0 million	140000

RSLS Revenue by Segment

Graph available only for paid members. Upgrade to see it.

RSLS

Price: $3.92

52 week price:

1.88

303.25

Earnings Per Share: 264.12 USD

P/E Ratio: 0.01

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 32400

Market Capitalization: 5.9 million

Links:

RSLS on Yahoo Finance